Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

166 results about "Urolithin" patented technology

Urolithins are microflora human metabolites of dietary ellagic acid derivatives such as ellagitannins. They are produced in the human gut, and found in the urine in the form of urolithin B glucuronide after absorption of ellagitannins-containing food such as pomegranate, strawberries, red raspberries, walnuts or oak-aged red wine.

Compositions comprising an urolithin compound

The invention provides compositions comprising a source of protein and a urolithin. The invention also provides uses and methods associated with, or making use of the compositions, such as a medicament, dietary supplement, functional food or medical food and in the treatment and / or prophylaxis of a muscle-related pathological condition. The invention also provides kits comprising urolithin and protein.
Owner:AMAZENTIS SA

Process-scale synthesis of urolithin A

Methods for preparing a salt of urolithin A and, in turn, urolithin A. Combining in an alkaline aqueous solution a copper-containing catalyst, 2-bromo-5-hydroxybenzoic acid, and resorcinol produces a salt of urolithin A. Urolithin A has been prepared by protonating a salt of the compound.
Owner:AMAZENTIS SA

Maltodextrin formulations

Disclosed are aqueous formulations comprising urolithins particularly water-based formulations comprising urolithins and maltodextrin. Also disclosed are compositions for admixture with water, methods for the preparation of such aqueous formulations, and to the uses of such formulations for both the treatment of diseases, disorders and conditions, for example, diseases disorders or conditions characterized by inadequate mitochondrial function and for administration to generally healthy individuals for example, for improving health and improving muscle function and performance.
Owner:AMAZENTIS SA

Fermented lactobacillus mucilaginosus FUA033 fermented cranberry juice product and preparation method thereof

The invention belongs to the field of microbial fermentation, and particularly relates to a fermented cranberry juice product prepared from fermented lactobacillus mucilaginosus FUA033 and a preparation method of the fermented cranberry juice product. The cranberry juice is fermented by using the fermentation lactobacillus mucus FUA033 capable of converting ellagic acid to generate urolithin A, the ellagic acid in the cranberry juice is converted into urolithin A with multiple biological activities of relieving muscle decline, resisting inflammation, resisting tumors and the like, the antioxidant activity of the cranberry juice is improved, the nutritional ingredients of the cranberry juice are enriched, and the cranberry juice is rich in nutrition and rich in nutrition. The cranberry juice prepared by the preparation method disclosed by the invention not only contains a plurality of antioxidant components, but also contains urolithin A with rich biological activity, can also provide probiotics such as lactobacillus mucus FUA033 and the like for a human body, and has a good application prospect.
Owner:JIANGSU OCEAN UNIV

Compositions comprising trigonelline and urolithin

Disclosed are compositions comprising a urolithin or a pharmaceutically acceptable salt thereof and trigonelline or a pharmaceutically acceptable salt thereof, and methods for use in increasing or maintaining mitochondrial function.
Owner:AMAZENTIS SA

Urolithin combination

The invention relates to compositions comprising urolithins with active agents, particularly compositions comprising urolithins and one or more ginseng-derived compounds or a ginseng extract; and / or one of more notoginseng-derived compounds or a notoginseng extract. The invention also relates to uses of such compositions, for use for the treatment or prevention of diseases, disorders and conditions, and for non-therapeutic uses.
Owner:AMAZENTIS SA

Cosmetic use of iso-urolithin a on sensitive skin

PCT designated stage expiredWO2025078619A1Cosmetic preparationsToilet preparationsUrolithinPharmacology
The present invention relates to the cosmetic use of at least iso-urolithin A and / or one of its salts and / or one of its solvates such as hydrates, for preventing and / or treating a skin manifestation on sensitive skin.
Owner:LOREAL SA

Application of urolithin A in preparation of medicine or health food for delaying ovarian senescence

The invention belongs to the technical field of biological medicines, and discloses application of urolithin A in preparation of medicines or health-care foods for delaying ovarian aging. The invention proves that by supplementing urolithin A, the fertility of the senescent ovary can be improved, the estrus cycle of the senescent ovary can be shortened, the fibrosis level of a senescent ovary matrix can be reduced, the ovary reserve capacity can be improved, the quality of a senescent ovary oocyte can be improved, and the fertilization and embryonic development potential can be improved; it is proved that urolithin A can be used as an effective component for preparing the medicine or health food for delaying ovarian aging.
Owner:THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIV

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

Provided are compositions comprising compounds or precursors to compounds which may be used for a variety of therapeutic applications including, for example, treating and / or preventing a disease or disorder related to reduced or inadequate mitochondrial activity, including aging or stress, diabetes, obesity, and neurodegenerative diseases. The compounds relate generally to urolithins and precursors thereof, including but not limited to ellagitannins and urolithin A. In certain embodiments the compositions are presented in or as food products or nutritional supplements. These same compounds and compositions can also be used advantageously in generally healthy individuals to increase or maintain metabolic rate, decrease percent body fat, increase or maintain muscle mass, manage body weight, improve or maintain mental performance (including memory), improve or maintain muscle performance, improve or maintain mood, and manage stress.
Owner:AMAZENTIS SA

Compositions comprising nicotinamide riboside and a urolithin

A composition comprising:a) nicotinamide riboside andb) a urolithin which is a compound of formula (I) or a salt thereof:wherein:A, B, C and D are each independently selected from H and OH;W, X and Y are each independently selected from H and OH; andZ is selected from H and OH.The compositions are useful as medicaments, for example for treating muscle-related pathological conditions, neurodegenerative diseases, and / or mitochondrial diseases and as dietary supplements, functional foods and beverages, and specialised nutrition or medical foods.
Owner:AMAZENTIS SA

Fermented lactobacillus mucilaginosus FUA033 fermented strawberry product and preparation method thereof

The invention belongs to the field of food fermentation, and particularly relates to a fermented strawberry product fermented by lactobacillus mucus FUA033 and a preparation method of the fermented strawberry product. On the basis of a fermentation technology, the fermented lactobacillus mucus FUA033 is used for fermenting the strawberry juice, so that the urolithin A is generated through fermentation and conversion, the smell and nutritional ingredients are enriched, and meanwhile, probiotics such as the fermented lactobacillus mucus FUA033 can be supplemented. The nutritional efficacy and value of strawberries are improved, the preparation technology of lactic acid bacteria applied to functional food is enriched, and the method has a good application prospect.
Owner:JIANGSU OCEAN UNIV

Urolithin gummy (pectin) formulations

The invention relates to composition of urolithins comprising urolithins and pectin and formulations of urolithins, specifically chewable formulations, comprising urolithins and a gelling agent. The invention further comprises compositions and chewable formulations comprising urolithins in combination with other active ingredients and processes for the preparation of such compositions and formulations. The invention further comprises methods of using such compositions and formulations in the treatment of conditions and diseases and for the promotion of health and performance, such in the improving muscle function.
Owner:AMAZENTIS SA

Nutraceutical composition for combating aging in human and non-human animals and beverages and / or food products and / or food supplements containing the same

A nutraceutical composition, consisting of Nicotinamide Mononucleotide in a range 250-1000 mg, Spermidine in a range 0.5-10 mg, Rhodiola Rosea in a range 200-600 mg, Cacao in a range 1000-10,000 mg, L-Theanine in a range 50-200 mg, Glucosamine in a range 500-3000 mg, and Hyaluronic acid in a range 50-240 mg, or consisting of Epigallocatechin-3-gallate in a range 100-500 mg, Quercetin in a range 250-1000 mg, Resveratrol in a range 150-1000 mg, Sulforaphane in a range 1-50 mg, and Calcium Alphaketoglutarate in a range 300-2000 mg, or consisting of Microdose Lithium in a range 1-5 mg, Trimethylglycine in a range 500-2000 mg, Glutathione in a range 250-1000 mg, Fisetin in a range 100-1000 mg, Urolithin A in a range 250-2000 mg, Sodium Butyrate in a range 100-3000 mg, Berberine in a range 500-1500 mg, Apigenin in a range 50-500 mg, Cinnamon in a range 1000-6000 mg, and Malate in a range 1000-6000 mg.
Owner:SPIEL DOUGLAS JAY +1

Combinations comprising an urolithin compound and a ginseng or notoginseng derived compound or a ginseng or notoginseng extract

PCT designated stage expiredWO2025088075A1Cosmetic preparationsNervous disorderDiseaseUrolithin
The invention relates to compositions comprising urolithins with active agents, particularly compositions comprising urolithins and one or more ginseng-derived compounds or a ginseng extract; and / or one of more notoginseng-derived compounds or a notoginseng extract. The invention also relates to uses of such compositions, for use for the treatment or prevention of diseases, disorders and conditions, and for non-therapeutic uses.
Owner:AMAZENTIS SA

Composition with anti-wrinkle, firming, whitening and brightening effects and application

The invention belongs to the technical field of health care products or daily chemical products, and particularly relates to a composition with anti-wrinkle, firming, whitening and brightening effects and application. The composition is prepared from the following components in parts by weight: 72 to 180 parts of fisetin, 120 to 180 parts of urolithin A and 5 to 15 parts of ergothioneine. Through precise component compounding, the synergistic interaction among fisetin, urolithin A and ergothioneine is brought into full play, the skin care composition integrating anti-wrinkle, firming, whitening and brightening functions is successfully developed, and the natural components of the skin care composition ensure the use safety of the product, so that the skin care composition has a good application prospect. The requirements of consumers on efficient skin care are effectively met.
Owner:HUNAN BANGSHANG YUANYI LIFE TECHNOLOGY CO LTD

Production process of urolithin A

The invention relates to the technical field of extraction and utilization of chemical substances in walnut green seedcases, in particular to a production process of urolithin A. The production process specifically comprises the following steps: obtaining the walnut green seedcases; walnut green seedcase is mashed into pulp, a stabilizing solution is added, ultrasonic treatment is performed after uniform stirring, the fermentation substrate is obtained, and the stabilizing solution is an aqueous solution of a compound of sulfydryl-beta-cyclodextrin and chitosan; primary fermentation: inoculating a microbial bacterial liquid A for anaerobic fermentation, then filtering and collecting filtrate, the microbial bacterial liquid A being obtained by respectively inoculating bacillus velezensis and bacillus coagulans into a culture medium A for shake cultivation and activation and then mixing the bacillus velezensis and the bacillus coagulans; secondary fermentation: inoculating the filtrate with a microbial bacterial liquid B for anaerobic fermentation again, wherein the microbial bacterial liquid B is obtained by inoculating enterococcus faecium into a culture medium B for culture; and extracting. According to the method, the stabilizing solution is added into the walnut green seedcase, and two-stage fermentation is performed, so that the yield and the conversion rate of urolithin A are remarkably improved, and the method is safe, environmentally friendly and capable of being industrialized.
Owner:HANGZHOU ZHONGNIU BIO-TECH CO LTD

Pediococcus acidilactici, microbial inoculum containing pediococcus acidilactici, application of microbial inoculum, sorghum fermented food and preparation method of sorghum fermented food

The invention relates to the technical field of food engineering, and discloses pediococcus acidilactici, a microbial agent containing the pediococcus acidilactici, application of the microbial agent, sorghum fermented food and a preparation method of the sorghum fermented food. The preservation number of the pediococcus acidilactici is GDMCC (China General Microbiological Culture Collection Center) No.65676, and the pediococcus acidilactici can be used for preparing the pediococcus acidilactici. The microbial agent contains pediococcus acidilactici and auxiliary bacteria. According to the sorghum fermented food obtained through fermentation treatment of the fungicide, antinutritional factors such as tannin in sorghum can be converted into urolithin, hydrolysis of protein, fat and starch can be promoted, the utilization rate of the sorghum is increased, the quality and flavor of fermented products are improved, the fermentation period is shortened, the shelf life is prolonged, and high economic benefits are achieved.
Owner:NANJING NORMAL UNIVERSITY

Compositions and methods to potentiate musculoskeletal effect of one or more anabolic amino acids on bone health

A method of improving and / or enhancing at least one of bone mineralization, bone strength, bone mass, and bone mineral density in an individual in need thereof, the method comprising administering to the individual a composition comprising one or more anabolic amino acids, and the composition further comprising one or more autophagy-inducing compounds. In one embodiment, the one or more autophagy-inducing compounds are selected from the group consisting of thymol, carvacrol, spermidine, urolithin (e.g., Urolithin A, B or D), rapamycin, Torin1, valproic acid, polyphenols (e.g., resveratrol), caffeine, metformin, 5′ AMP-activated protein kinase (AMPK) activators, L-type calcium channel inhibitors, ketones (e.g. beta-hydroxybutyrate, ketone salts, or ketone ester derivatives), 4,4′-dimethoxychalcone and mixtures thereof.
Owner:SOCIETE DES PRODUITS NESTLE SA

Culture medium for improving efficiency of transforming ellagic acid to generate urolithin A by lactobacillus mucus FUA033 and application of culture medium

The invention belongs to the field of microbial fermentation, and particularly relates to a culture medium for improving the efficiency of converting ellagic acid into urolithin A by lactobacillus mucus FUA033 and application of the culture medium. On the basis of a fermentation technology, under the same fermentation condition, the efficiency of converting ellagic acid to generate urolithin A by fermenting lactobacillus mucus FUA033 is improved by 21.13% and reaches 75.21% by optimizing a culture medium. The lactobacillus mucilaginosus FUA033 provides a technical support for preparing urolithin A through industrial green fermentation of the lactobacillus mucilaginosus FUA033 and developing fermented food rich in urolithin A, and has a good application prospect.
Owner:JIANGSU OCEAN UNIV

Application of urolithin D in preparation of medicine for relieving hyperuricemia

The invention belongs to the field of biological medicine, and particularly relates to application of urolithin D in preparation of medicine for relieving hyperuricemia. It is found for the first time that the urolithin D can significantly reduce the level of serum uric acid, improve the expression disorder of a kidney urate transporter, efficiently relieve or treat hyperuricemia and related diseases thereof, and relieve kidney injury and fibrosis; and the compound can be used for preparing medicines for treating hyperuricemia and related diseases, is low in cost and good in safety, and has a wide application prospect.
Owner:SHANDONG ACADEMY OF AGRICULTURAL SCIENCES

Application of urolithin A in Alzheimer's disease

The invention provides application of urolithin A in Alzheimer's disease, belongs to the technical field of medicinal chemistry and treatment of mental diseases, and aims to solve the problem of social anxiety caused by the Alzheimer's disease. According to the application disclosed by the invention, the mitochondrial autophagy effect of urolithin A is utilized, A beta is eliminated, a key brain region loop aBLA-vCA1 is repaired, and the anxiety symptom of a patient suffering from the Alzheimer's disease is relieved. According to the present invention, with the application of the urolithin A in the treatment of Alzheimer's disease, through the mitochondrial autophagy function of the urolithin A, the targeted removal of A beta and the repair of the damaged basal outer side amygdala nucleus and hippocampus loop are achieved so as to effectively relieve the anxiety symptom of the patient and provide the new strategy for the AD treatment.
Owner:SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION (SHENZHEN HEALTH INSPECTION CENTER SHENZHEN INSTITUTE OF PREVENTIVE MEDICINE)

Chewable compositions comprising pectin and urolithin

PCT designated stage expiredWO2024246296A1ConfectioneryMuscular disorderDiseaseUrolithin
The invention relates to composition of urolithins comprising urolithins and pectin and formulations of urolithins, specifically chewable formulations, comprising urolithins and a gelling agent. The invention further comprises compositions and chewable formulations comprising urolithins in combination with other active ingredients and processes for the preparation of such compositions and formulations. The invention further comprises methods of using such compositions and formulations in the treatment of conditions and diseases and for the promotion of health and performance, such in the improving muscle function.
Owner:AMAZENTIS SA

Compositions comprising punica granatum whole spectrum extract selectively enriched with punicagalins, ellagic acid and urolethin a and process for preparation thereof

The present invention discloses compositions of Punica granatum whole spectrum extract (PWSE) extract comprising Urolithin A in the range of 0.2% - 10%, for improving general health, overall wellbeing and longevity by preventing age related disorders. The invention further discloses compositions comprising Punica granatum whole spectrum extract enriched with Punicagalins, Ellagic acid and Urolethin A. The invention additionally discloses a process for preparation of Punica granatum whole spectrum extract selectively enriched to comprise Punicagalins, Ellagic acid and Urolethin A.
Owner:SUTHAR JASPREET

Combination of urolithin and immunotherapy treatments

The present invention relates to a combination of urolithin and immunotherapy treatments, in particular a combination of urolithin and a therapeutic agent, in particular a combination of urolithin and immunotherapy treatments, such as a PD-1 antagonist, and an immune checkpoint blocking therapy. The invention also relates to pharmaceutical compositions comprising said combination, processes for the preparation of said pharmaceutical compositions and methods of using said compositions in the treatment of disease. In one embodiment, the immune checkpoint blocking therapy is selected from the group consisting of an anti-PD-1 antibody, an anti-PD-L1 antibody, an anti-CTLA4 antibody, or a fusion protein.
Owner:AMAZENTIS SA

Use of urolithin to prevent / slow down hair thinning

Use of a urolithin to prevent / slow down hair thinning. The present invention relates to the cosmetic use of at least one compound of formula (I) and / or one of its salts and / or solvates and / or one of its glucuronide derivatives to prevent / slow down hair thinning, and / or promote increased hair thickness. Figure for the abstract: none
Owner:LOREAL SA

Application of urolithin A in treatment of multiple organ injuries caused by sepsis

The invention belongs to the technical field of pharmacy, and particularly relates to application of urolithin A in treating multiple organ injuries caused by sepsis. Experiments prove that the urolithin A can significantly reduce the apoptosis rate of bone marrow-derived macrophages, and can effectively relieve multi-organ injury caused by sepsis by regulating three key paths including oxidative stress, cell apoptosis and necrotic apoptosis. The application provides solid experimental basis and theoretical support for development of urolithin A as a sepsis treatment drug, and has important conversion value and clinical application prospect in the critical disease medical field.
Owner:ANHUI MEDICAL UNIV

Compositions and methods for supporting mitochondrial health

Methylthioninium salt-containing compositions can include a methylthioninium salt and a second mitochondria-enhancing compound selected from urolithin A having a methylthioninium salt to urolithin A weight ratio from about 1:600 to about 1:4, pyrroloquinoline quinone having a methylthioninium salt to pyrroloquinoline quinone weight ratio from about 1:20 to about 50:1, tesofensine having a methylthioninium salt to tesofensine weight ratio from about 1:2 to about 100:1, or a combination thereof.
Owner:LOPEZ DARREN +1